TickerKhojComparison · NSE · data 2026-11-03
Orchid Pharma Limited vs Senores Pharmaceuticals Ltd.
In plain words
Size: Senores Pharmaceuticals Ltd. is about 1 times the market value of Orchid Pharma Limited.
Valuation (P/E): Orchid Pharma Limited 493.5 vs Senores Pharmaceuticals Ltd. 39.7.
Return on equity: Senores Pharmaceuticals Ltd. 13.4% vs Orchid Pharma Limited 0.7%.
Profit growth over 3 years: Senores Pharmaceuticals Ltd. 139.2% a year vs Orchid Pharma Limited -40.1% a year.
Debt to equity: Senores Pharmaceuticals Ltd. 0.37 vs Orchid Pharma Limited 0.2.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| ORCHPHARMA | SENORES | |
|---|---|---|
| Price | ₹843.25 | ₹1,147 |
| Market cap | ₹5,066 cr | ₹5,157 cr |
| P/E | 493.5 | 39.7 |
| P/B | — | 5.3 |
| ROE | 0.7% | 13.4% |
| ROCE | 0.2% | 12.6% |
| Debt / equity | 0.2 | 0.37 |
| Operating margin | 0.3% | 24.3% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 22.7% | 161.6% |
| Profit growth, 3 years (yearly) | -40.1% | 139.2% |
| 1-year return | 17.9% | 48.7% |
| Revenue, last 12 months | ₹943 cr | ₹722 cr |
| Net profit, last 12 months | ₹9 cr | ₹133 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹3 cr | ₹39 cr |
| Quarter profit vs a year earlier | -78.4% | +22.0% |
| Promoter holding | 74.45% | 45.82% |
| Health check | Weak (3.5/10) | Strong (7.2/10) |
Common questions
Which has a higher P/E, Orchid Pharma Limited or Senores Pharmaceuticals Ltd.?
Orchid Pharma Limited trades at the higher P/E (493.5 against 39.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Senores Pharmaceuticals Ltd. (13.4% against 0.7%).
Which carries more debt?
Senores Pharmaceuticals Ltd. has the higher debt-to-equity ratio (0.37 against 0.2).